PharmaKure announces epigenetics collaboration with Sheffield Hallam University to understand mechanisms of Alzheimer’s Diseases

Petrovax has announced encouraging findings from the Long-CoV-III-21 trial, a randomised, double-blind, placebo-controlled study evaluating the efficacy and safety of Longidaza (3000 U) for treating

Pfiz­er no longer plans to read out an in­ter­im analy­sis on its Duchenne mus­cu­lar dy­s­tro­phy gene ther­a­py pro­gram by the end of the year, it